Request for Covid-19 Impact Assessment of this Report
The United States Teriparatide Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Teriparatide Injection market, reaching US$ million by the year 2028. As for the Europe Teriparatide Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Teriparatide Injection players cover Eli Lilly and Company, Alvogen, Pfenex Inc., and Shenzhen Salubris Pharmaceuticals Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Teriparatide Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2.5 ML
3.0 ML
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eli Lilly and Company
Alvogen
Pfenex Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Shanghai United Cell Biotechnology Co., Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Teriparatide Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Teriparatide Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Teriparatide Injection by Country/Region, 2017, 2022 & 2028
2.2 Teriparatide Injection Segment by Type
2.2.1 2.5 ML
2.2.2 3.0 ML
2.3 Teriparatide Injection Sales by Type
2.3.1 Global Teriparatide Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Teriparatide Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Teriparatide Injection Sale Price by Type (2017-2022)
2.4 Teriparatide Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Teriparatide Injection Sales by Application
2.5.1 Global Teriparatide Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Teriparatide Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Teriparatide Injection Sale Price by Application (2017-2022)
3 Global Teriparatide Injection by Company
3.1 Global Teriparatide Injection Breakdown Data by Company
3.1.1 Global Teriparatide Injection Annual Sales by Company (2020-2022)
3.1.2 Global Teriparatide Injection Sales Market Share by Company (2020-2022)
3.2 Global Teriparatide Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Teriparatide Injection Revenue by Company (2020-2022)
3.2.2 Global Teriparatide Injection Revenue Market Share by Company (2020-2022)
3.3 Global Teriparatide Injection Sale Price by Company
3.4 Key Manufacturers Teriparatide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Teriparatide Injection Product Location Distribution
3.4.2 Players Teriparatide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Teriparatide Injection by Geographic Region
4.1 World Historic Teriparatide Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Teriparatide Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Teriparatide Injection Annual Revenue by Geographic Region
4.2 World Historic Teriparatide Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Teriparatide Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Teriparatide Injection Annual Revenue by Country/Region
4.3 Americas Teriparatide Injection Sales Growth
4.4 APAC Teriparatide Injection Sales Growth
4.5 Europe Teriparatide Injection Sales Growth
4.6 Middle East & Africa Teriparatide Injection Sales Growth
5 Americas
5.1 Americas Teriparatide Injection Sales by Country
5.1.1 Americas Teriparatide Injection Sales by Country (2017-2022)
5.1.2 Americas Teriparatide Injection Revenue by Country (2017-2022)
5.2 Americas Teriparatide Injection Sales by Type
5.3 Americas Teriparatide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Teriparatide Injection Sales by Region
6.1.1 APAC Teriparatide Injection Sales by Region (2017-2022)
6.1.2 APAC Teriparatide Injection Revenue by Region (2017-2022)
6.2 APAC Teriparatide Injection Sales by Type
6.3 APAC Teriparatide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Teriparatide Injection by Country
7.1.1 Europe Teriparatide Injection Sales by Country (2017-2022)
7.1.2 Europe Teriparatide Injection Revenue by Country (2017-2022)
7.2 Europe Teriparatide Injection Sales by Type
7.3 Europe Teriparatide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Teriparatide Injection by Country
8.1.1 Middle East & Africa Teriparatide Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Teriparatide Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Teriparatide Injection Sales by Type
8.3 Middle East & Africa Teriparatide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Teriparatide Injection
10.3 Manufacturing Process Analysis of Teriparatide Injection
10.4 Industry Chain Structure of Teriparatide Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Teriparatide Injection Distributors
11.3 Teriparatide Injection Customer
12 World Forecast Review for Teriparatide Injection by Geographic Region
12.1 Global Teriparatide Injection Market Size Forecast by Region
12.1.1 Global Teriparatide Injection Forecast by Region (2023-2028)
12.1.2 Global Teriparatide Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Teriparatide Injection Forecast by Type
12.7 Global Teriparatide Injection Forecast by Application
13 Key Players Analysis
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Teriparatide Injection Product Offered
13.1.3 Eli Lilly and Company Teriparatide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Alvogen
13.2.1 Alvogen Company Information
13.2.2 Alvogen Teriparatide Injection Product Offered
13.2.3 Alvogen Teriparatide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alvogen Main Business Overview
13.2.5 Alvogen Latest Developments
13.3 Pfenex Inc.
13.3.1 Pfenex Inc. Company Information
13.3.2 Pfenex Inc. Teriparatide Injection Product Offered
13.3.3 Pfenex Inc. Teriparatide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfenex Inc. Main Business Overview
13.3.5 Pfenex Inc. Latest Developments
13.4 Shenzhen Salubris Pharmaceuticals Co., Ltd.
13.4.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Company Information
13.4.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Offered
13.4.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Main Business Overview
13.4.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Latest Developments
13.5 Shanghai United Cell Biotechnology Co., Ltd.
13.5.1 Shanghai United Cell Biotechnology Co., Ltd. Company Information
13.5.2 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Offered
13.5.3 Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Shanghai United Cell Biotechnology Co., Ltd. Main Business Overview
13.5.5 Shanghai United Cell Biotechnology Co., Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Teriparatide Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Teriparatide Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2.5 ML
Table 4. Major Players of 3.0 ML
Table 5. Global Teriparatide Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Teriparatide Injection Sales Market Share by Type (2017-2022)
Table 7. Global Teriparatide Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Teriparatide Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Teriparatide Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Teriparatide Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Teriparatide Injection Sales Market Share by Application (2017-2022)
Table 12. Global Teriparatide Injection Revenue by Application (2017-2022)
Table 13. Global Teriparatide Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Teriparatide Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Teriparatide Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Teriparatide Injection Sales Market Share by Company (2020-2022)
Table 17. Global Teriparatide Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Teriparatide Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Teriparatide Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Teriparatide Injection Producing Area Distribution and Sales Area
Table 21. Players Teriparatide Injection Products Offered
Table 22. Teriparatide Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Teriparatide Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Teriparatide Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Teriparatide Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Teriparatide Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Teriparatide Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Teriparatide Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Teriparatide Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Teriparatide Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Teriparatide Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Teriparatide Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Teriparatide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Teriparatide Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Teriparatide Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Teriparatide Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Teriparatide Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Teriparatide Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Teriparatide Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Teriparatide Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Teriparatide Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Teriparatide Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Teriparatide Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Teriparatide Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Teriparatide Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Teriparatide Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Teriparatide Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Teriparatide Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Teriparatide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Teriparatide Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Teriparatide Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Teriparatide Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Teriparatide Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Teriparatide Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Teriparatide Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Teriparatide Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Teriparatide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Teriparatide Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Teriparatide Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Teriparatide Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Teriparatide Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Teriparatide Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Teriparatide Injection
Table 66. Key Market Challenges & Risks of Teriparatide Injection
Table 67. Key Industry Trends of Teriparatide Injection
Table 68. Teriparatide Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Teriparatide Injection Distributors List
Table 71. Teriparatide Injection Customer List
Table 72. Global Teriparatide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Teriparatide Injection Sales Market Forecast by Region
Table 74. Global Teriparatide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Teriparatide Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Teriparatide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Teriparatide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Teriparatide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Teriparatide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Teriparatide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Teriparatide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Teriparatide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Teriparatide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Teriparatide Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Teriparatide Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Teriparatide Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Teriparatide Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Teriparatide Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Teriparatide Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Teriparatide Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Teriparatide Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Eli Lilly and Company Basic Information, Teriparatide Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly and Company Teriparatide Injection Product Offered
Table 94. Eli Lilly and Company Teriparatide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Eli Lilly and Company Main Business
Table 96. Eli Lilly and Company Latest Developments
Table 97. Alvogen Basic Information, Teriparatide Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Alvogen Teriparatide Injection Product Offered
Table 99. Alvogen Teriparatide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Alvogen Main Business
Table 101. Alvogen Latest Developments
Table 102. Pfenex Inc. Basic Information, Teriparatide Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfenex Inc. Teriparatide Injection Product Offered
Table 104. Pfenex Inc. Teriparatide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Pfenex Inc. Main Business
Table 106. Pfenex Inc. Latest Developments
Table 107. Shenzhen Salubris Pharmaceuticals Co., Ltd. Basic Information, Teriparatide Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Product Offered
Table 109. Shenzhen Salubris Pharmaceuticals Co., Ltd. Teriparatide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Shenzhen Salubris Pharmaceuticals Co., Ltd. Main Business
Table 111. Shenzhen Salubris Pharmaceuticals Co., Ltd. Latest Developments
Table 112. Shanghai United Cell Biotechnology Co., Ltd. Basic Information, Teriparatide Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Product Offered
Table 114. Shanghai United Cell Biotechnology Co., Ltd. Teriparatide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Shanghai United Cell Biotechnology Co., Ltd. Main Business
Table 116. Shanghai United Cell Biotechnology Co., Ltd. Latest Developments
List of Figures
Figure 1. Picture of Teriparatide Injection
Figure 2. Teriparatide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Teriparatide Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Teriparatide Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Teriparatide Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2.5 ML
Figure 10. Product Picture of 3.0 ML
Figure 11. Global Teriparatide Injection Sales Market Share by Type in 2021
Figure 12. Global Teriparatide Injection Revenue Market Share by Type (2017-2022)
Figure 13. Teriparatide Injection Consumed in Hospital
Figure 14. Global Teriparatide Injection Market: Hospital (2017-2022) & (K Units)
Figure 15. Teriparatide Injection Consumed in Clinic
Figure 16. Global Teriparatide Injection Market: Clinic (2017-2022) & (K Units)
Figure 17. Teriparatide Injection Consumed in Others
Figure 18. Global Teriparatide Injection Market: Others (2017-2022) & (K Units)
Figure 19. Global Teriparatide Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Teriparatide Injection Revenue Market Share by Application in 2021
Figure 21. Teriparatide Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Teriparatide Injection Revenue Market Share by Company in 2021
Figure 23. Global Teriparatide Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Teriparatide Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Teriparatide Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Teriparatide Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Teriparatide Injection Sales 2017-2022 (K Units)
Figure 28. Americas Teriparatide Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Teriparatide Injection Sales 2017-2022 (K Units)
Figure 30. APAC Teriparatide Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Teriparatide Injection Sales 2017-2022 (K Units)
Figure 32. Europe Teriparatide Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Teriparatide Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Teriparatide Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Teriparatide Injection Sales Market Share by Country in 2021
Figure 36. Americas Teriparatide Injection Revenue Market Share by Country in 2021
Figure 37. United States Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Teriparatide Injection Sales Market Share by Region in 2021
Figure 42. APAC Teriparatide Injection Revenue Market Share by Regions in 2021
Figure 43. China Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Teriparatide Injection Sales Market Share by Country in 2021
Figure 50. Europe Teriparatide Injection Revenue Market Share by Country in 2021
Figure 51. Germany Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Teriparatide Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Teriparatide Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Teriparatide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Teriparatide Injection in 2021
Figure 64. Manufacturing Process Analysis of Teriparatide Injection
Figure 65. Industry Chain Structure of Teriparatide Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...